While other global approvals were were focused on prevention, this is the first approval for SaNOtize nasal spray as early treatment for COVID-19.

Glenmark Pharmaceuticals will manufacture the spray in India and intends to produce, market and distribute it to other Asian countries.

SaNOtize is increasing production in Israel and beyond as it attempts to keep up with international demand for its Enovid nasal spray.

SaNOtize signed a deal with India's Glenmark Pharmaceuticals to market and sell their Nitric Oxide Nasal Spray (NONS) in India, Vietnam, and more.

Enovid, SaNOtize’s Nitric Oxide Nasal Spray (NONS), will be sold in Israel after receiving emergency use authorization as a medical device by the Ministry of Health.